LOGGI, ELISABETTA
LOGGI, ELISABETTA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
Adaptive response in Hepatitis B virus infection
2014 Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P.
Alcoholic liver disease: pathophisiological aspects and risk factors. A review.
2006 Gramenzi A; Caputo F; Biselli M; Kuria F; Loggi E; Andreone P; Bernardi M.
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
2009 Loggi E; Bihl F; Chisolm JV 3rd; Biselli M; Bontadini A; Vitale G; Ercolani G; Grazi GL; Pinna AD; Bernardi M; Brander C; Andreone P.
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C.
2012 Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M.; Brillanti S.; Andreone P.
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B
2010 Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C.
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients.
2014 Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P.
Chronic hepatitis B: Are we close to a cure?
2015 Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone .
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV.
2012 Fisicaro P.; Valdatta C.; Massari M.; Loggi E.; Ravanetti L.; Urbani S.; Giuberti T.; Cavalli A.; Vandelli C.; Andreone P.; Missale G.; Ferrari C.
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.
2005 Gramenzi A.; Andreone P.; Loggi E.; Foschi F.G.; Cursaro C.; Margotti M.; Biselli M.; Bernardi M.
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies
2015 Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects.
2013 G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A.F. Cicero, M. Bernardi, P. Andreone
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
2013 Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; Bihl F; Andreone P; Maini MK.
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis.
2005 Foschi F.G.; Trevisani F.; Loggi E.; Parazza M.; Melotti C.; Bedeschi E.; Mingazzini L.; Mirici Cappa F.; Cescon M.; Andreone P.; Grazi G.; Stefanini G.F.; Bernardi M.
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS).
2005 Lorenzini S.; Isidori A.; Loggi E.;Gramenzi A.; Catani L.; Talarico S.; Cursaro C.; Biselli M.; Bonifazi F.; Lemoli RM.; Baccarani M.; Bernardi M.; Andreone P.
Hepatitis B virus and immune response.
2008 Fiorino S; Vukotic R; Loggi E; Vitale G; Cursaro C; Gramenzi A; Micco L; Fortini C; Cuppini A; Bernardi M; Andreone P.
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice
2017 Loggi, Elisabetta; Gitto, Stefano; Galli, Silvia; Minichiello, Mario; Conti, Fabio; Grandini, Elena; Scuteri, Alessandra; Vitale, Giovanni; Di Donato, Roberto; Cursaro, Carmela; Furlini, Giuliano; Andreone, Pietro*
Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire
2008 Tan AT; Loggi E; Boni C; Chia A; Gehring AJ; Sastry KS; Goh V; Fisicaro P; Andreone P; Brander C; Lim SG; Ferrari C; Bihl F; Bertoletti A.
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C.
2010 Grandini E; Cannoletta F; Scuteri A; Fortini C; Loggi E; Cursaro C; Riili A; Di Donato R; Gramenzi A; Bernardi M; Andreone P.
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome
2002 Trevisani F.; Castelli E.; Foschi F.G.; Parazza M.; Loggi E.; Bertelli M.; Melotti C.; Domenicali M.; Zoli G.; Bernardi M.
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
2004 Andreone P.; Gramenzi A.; Loggi E.; Favarelli L.; Cursaro C.; Margotti M.; Biselli M.; Lorenzini S.; Bernardi M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Adaptive response in Hepatitis B virus infection | Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P. | 2014-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Alcoholic liver disease: pathophisiological aspects and risk factors. A review. | Gramenzi A; Caputo F; Biselli M; Kuria F; Loggi E; Andreone P; Bernardi M. | 2006-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft | Loggi E; Bihl F; Chisolm JV 3rd; Biselli M; Bontadini A; Vitale G; Ercolani G; Grazi GL; Pinna AD...; Bernardi M; Brander C; Andreone P. | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. | Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M....; Brillanti S.; Andreone P. | 2012-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B | Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreo...ne P; Missale G; Ferrari C. | 2010-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. | Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P. | 2014-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Chronic hepatitis B: Are we close to a cure? | Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone . | 2015-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. | Fisicaro P.; Valdatta C.; Massari M.; Loggi E.; Ravanetti L.; Urbani S.; Giuberti T.; Cavalli A.;... Vandelli C.; Andreone P.; Missale G.; Ferrari C. | 2012-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. | Gramenzi A.; Andreone P.; Loggi E.; Foschi F.G.; Cursaro C.; Margotti M.; Biselli M.; Bernardi M. | 2005-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies | Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina...; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda | 2015-01-01 | HEPATOLOGY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. | G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A....F. Cicero, M. Bernardi, P. Andreone | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. | Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; B...ihl F; Andreone P; Maini MK. | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. | Foschi F.G.; Trevisani F.; Loggi E.; Parazza M.; Melotti C.; Bedeschi E.; Mingazzini L.; Mirici C...appa F.; Cescon M.; Andreone P.; Grazi G.; Stefanini G.F.; Bernardi M. | 2005-01-01 | INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). | Lorenzini S.; Isidori A.; Loggi E.;Gramenzi A.; Catani L.; Talarico S.; Cursaro C.; Biselli M.; B...onifazi F.; Lemoli RM.; Baccarani M.; Bernardi M.; Andreone P. | 2005-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Hepatitis B virus and immune response. | Fiorino S; Vukotic R; Loggi E; Vitale G; Cursaro C; Gramenzi A; Micco L; Fortini C; Cuppini A; Be...rnardi M; Andreone P. | 2008-01-01 | - | Nova Science Publishers Inc | 3.01 Monografia / trattato scientifico in forma di libro | - |
| Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice | Loggi, Elisabetta; Gitto, Stefano; Galli, Silvia; Minichiello, Mario; Conti, Fabio; Grandini, Ele...na; Scuteri, Alessandra; Vitale, Giovanni; Di Donato, Roberto; Cursaro, Carmela; Furlini, Giuliano; Andreone, Pietro* | 2017-01-01 | JOURNAL OF CLINICAL VIROLOGY | - | 1.01 Articolo in rivista | - |
| Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire | Tan AT; Loggi E; Boni C; Chia A; Gehring AJ; Sastry KS; Goh V; Fisicaro P; Andreone P; Brander C;... Lim SG; Ferrari C; Bihl F; Bertoletti A. | 2008-01-01 | JOURNAL OF VIROLOGY | - | 1.01 Articolo in rivista | - |
| Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. | Grandini E; Cannoletta F; Scuteri A; Fortini C; Loggi E; Cursaro C; Riili A; Di Donato R; Gramenz...i A; Bernardi M; Andreone P. | 2010-01-01 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | - | 1.01 Articolo in rivista | - |
| Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome | Trevisani F.; Castelli E.; Foschi F.G.; Parazza M.; Loggi E.; Bertelli M.; Melotti C.; Domenicali... M.; Zoli G.; Bernardi M. | 2002-01-01 | GUT | - | 1.01 Articolo in rivista | - |
| In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C | Andreone P.; Gramenzi A.; Loggi E.; Favarelli L.; Cursaro C.; Margotti M.; Biselli M.; Lorenzini ...S.; Bernardi M. | 2004-01-01 | CYTOKINE | - | 1.01 Articolo in rivista | - |